As of 2026-04-05, the Intrinsic Value of Immunovant Inc (IMVT) is -11.40 USD. This IMVT valuation is based on the model Peter Lynch Fair Value. With the current market price of 24.50 USD, the upside of Immunovant Inc is -146.55%.
Based on its market price of 24.50 USD and our intrinsic valuation, Immunovant Inc (IMVT) is overvalued by 146.55%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -11.40 - -11.40 | -11.40 | -146.55% |
| P/E | (45.39) - (52.37) | (49.83) | -303.4% |
| DDM - Stable | (13.25) - (36.17) | (24.71) | -200.9% |
| DDM - Multi | (1.33) - (2.85) | (1.82) | -107.4% |
| Market Cap (mil) | 4,986.48 |
| Beta | 1.26 |
| Outstanding shares (mil) | 203.53 |
| Enterprise Value (mil) | 3,991.96 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.86% |
| Cost of Debt | 5.00% |
| WACC | 8.93% |